Sanofi Pasteur
Prevenar 13 rejected for UK vaccination programme
July 27, 2012Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13
The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …
Digital Pharma: Sanofi Pasteur MSD takes Quora approach to vaccines
May 6, 2011Medical Communications Digital Pharma blog, Sanofi Pasteur, vaccines
Sanofi Pasteur MSD is aiming to tackle myths and misconceptions about vaccines with a Quora-like online health information campaign in …
Sanofi partners on dengue vaccine awareness
February 22, 2011Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines
Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …
Sanofi’s C diff vaccine fast tracked by FDA
November 10, 2010Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur
A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …
Sanofi plant in France under FDA scrutiny
August 3, 2010Manufacturing and Production Sanofi Pasteur, manufacturing compliance
Sanofi-Aventis failed to follow proper quality control procedures at a vaccine manufacturing plant in France, according to the US Food …
Sanofi to develop monoclonal antibody jabs
June 8, 2010Research and Development Sanofi Pasteur, Vivalis, vaccines
Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …
Sanofi refocuses its French manufacturing capacity
April 1, 2010Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics
Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …
Sanofi’s Humenza poised to be Europe’s fifth swine flu vaccine
February 22, 2010Sales and Marketing Sanofi Pasteur, Tyverb, Zeftera, swine flu
Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …
Sanofi Pasteur collaborates on novel biologics
January 12, 2010Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines
Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
